Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Sntb2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SNTB2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Sntb2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SNTB2 mRNA | CTD | PMID:19465110 more ... | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SNTB2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SNTB2 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Sntb2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNTB2 mRNA | CTD | PMID:21570461 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 4-hydroxyphenyl retinamide | increases expression | ISO | Sntb2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of SNTB2 mRNA | CTD | PMID:28973697 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Sntb2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SNTB2 mRNA | CTD | PMID:28973697 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of SNTB2 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SNTB2 mRNA | CTD | PMID:22100608 | aflatoxin B1 | decreases methylation | ISO | SNTB2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SNTB2 gene | CTD | PMID:27153756 | antirheumatic drug | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of SNTB2 mRNA | CTD | PMID:24449571 | Aroclor 1254 | increases expression | ISO | Sntb2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of SNTB2 mRNA | CTD | PMID:25270620 | benzo[a]pyrene | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SNTB2 mRNA | CTD | PMID:20064835 | beta-hexachlorocyclohexane | increases expression | ISO | Sntb2 (Mus musculus) | 6480464 | beta-hexachlorocyclohexane results in increased expression of SNTB2 mRNA | CTD | PMID:25270620 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SNTB2 mRNA | CTD | PMID:30816183 and PMID:34947998 | bisphenol A | increases methylation | ISO | SNTB2 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of SNTB2 gene | CTD | PMID:31601247 | Bisphenol B | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of SNTB2 protein | CTD | PMID:34186270 | bisphenol F | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of SNTB2 protein | CTD | PMID:34186270 | caffeine | affects phosphorylation | ISO | SNTB2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of SNTB2 protein | CTD | PMID:35688186 | carbamazepine | affects expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of SNTB2 mRNA | CTD | PMID:25979313 | cerium trichloride | increases expression | ISO | Sntb2 (Mus musculus) | 6480464 | cerous chloride results in increased expression of SNTB2 mRNA | CTD | PMID:23573234 | cisplatin | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of SNTB2 mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of SNTB2 mRNA | CTD | PMID:19320972 | cobalt dichloride | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of SNTB2 mRNA | CTD | PMID:19376846 | copper(II) sulfate | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SNTB2 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | SNTB2 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of SNTB2 protein | CTD | PMID:35688186 | dexamethasone | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of SNTB2 mRNA | CTD | PMID:25047013 | dorsomorphin | multiple interactions | ISO | SNTB2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SNTB2 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of SNTB2 mRNA | CTD | PMID:29391264 | entinostat | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | entinostat results in decreased expression of SNTB2 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | SNTB2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNTB2 mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of SNTB2 mRNA | CTD | PMID:23649840 | folic acid | decreases expression | ISO | Sntb2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SNTB2 mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of SNTB2 mRNA | CTD | PMID:23649840 | FR900359 | affects phosphorylation | ISO | SNTB2 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of SNTB2 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SNTB2 mRNA | CTD | PMID:33387578 | glycidol | increases expression | EXP | | 6480464 | glycidol results in increased expression of SNTB2 mRNA | CTD | PMID:24915197 | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of SNTB2 gene | CTD | PMID:35440735 | Heptachlor epoxide | increases expression | ISO | Sntb2 (Mus musculus) | 6480464 | Heptachlor Epoxide results in increased expression of SNTB2 mRNA | CTD | PMID:25270620 | ivermectin | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SNTB2 protein | CTD | PMID:32959892 | lead diacetate | increases expression | ISO | Sntb2 (Mus musculus) | 6480464 | lead acetate results in increased expression of SNTB2 mRNA | CTD | PMID:22613225 | methyl methanesulfonate | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SNTB2 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of SNTB2 mRNA | CTD | PMID:28001369 | resveratrol | multiple interactions | ISO | SNTB2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of SNTB2 mRNA | CTD | PMID:23557933 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of SNTB2 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | SNTB2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | Sntb2 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of SNTB2 mRNA | CTD | PMID:23221170 | sodium arsenate | decreases expression | ISO | Sntb2 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of SNTB2 mRNA | CTD | PMID:21795629 | sodium arsenite | increases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SNTB2 mRNA | CTD | PMID:28595984 | sodium fluoride | decreases expression | ISO | Sntb2 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of SNTB2 protein | CTD | PMID:28918527 | sunitinib | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SNTB2 mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | ISO | Sntb2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SNTB2 mRNA | CTD | PMID:31919559 | valproic acid | affects expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SNTB2 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | SNTB2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNTB2 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SNTB2 mRNA | CTD | PMID:26272509 and PMID:28001369 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of SNTB2 mRNA | CTD | PMID:23034163 | vitamin E | decreases expression | ISO | SNTB2 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of SNTB2 mRNA | CTD | PMID:19244175 | |